|Gene therapy cocktail shows promise in long-term clinical trial for rare fatal brain disorder|
|Wednesday, December 19, 2012|
Results of a clinical trial that began in 2001 show that a gene therapy cocktail conveyed into the brain by a molecular special delivery vehicle may help extend the lives of children with Canavan disease, a rare and fatal neurodegenerative disorder.
A report of the trial appears in the Dec. 19, 2012 online edition of the journal Science Translational Medicine.
For full release
CAROLINA IN THE NEWSUNC Loses a B-School Dean, Gains a Provost
The Kenan-Flagler Business School at the University of North Carolina, Chapel Hill, is losing its dean, Jim Dean, who has been appointed executive vice chancellor and provost for the university effective July 1. The appointment was announced to the campus community on May 23 in an email from Chancellor Holden Thorp and Chancellor-Elect Carol Folt, following a vote by the University’s Board of Trustees earlier in the day.